Switching Antidepressant: References
Uhr M, Tontsch A, Namendorf C, et al. Polymorphisms in the Drug Transporter Gene ABCB1 Predict Antidepressant Treatment Response in Depression. Neuron. 2008; 57 (2): 203-9.
Kato M, Fukuda T, Serretti A, et al. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Prog Neuropsych Biol Psych. 32 (2):398-404.
Leuchter AF, Cook IA, Marangell LB, et al. Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study. Psychiatry Res. 2009 30;169(2):124-31.
Howland RH, Wilson MG, Kornstein SG, et al. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression. Ann Clin Psychiatry. 2008;20(4):209-18.
Young EA, Kornstein SG, Marcus SM, et al. Sex differences in response to citalopram: a STAR*D report. J Psychiatr Res. 2009 Feb;43(5):503-11.
Trivedi MH, Rush AJ, Wisniewski SR, et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STARâˆ—D: Implications for clinical practice. Am J Psychiatry. 2006;163:28-40.
Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet. 2003;361(9358):653.
Mueller TI, Leon AC, Keller MB, et al. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156(7):1000-1006.
Judd LL, Paulus MJ, Schettler PJ, et al. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry. 2000;157(9):1501-1504.
Kupfer DJ, Frank E, Perel JM, et al. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1992;49(10):769-773.
Simon GE, Von Korff M, Rutter CM, Peterson DA. Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians. Arch Gen Psychiatry. 2001;58(4):395-
Weilburg JB, O'Leary KM, Meigs JB, et al. Evaluation of the adequacy of outpatient antidepressant treatment. Psychiatr Serv. 2003;54(9):1233-9.
Lin EH, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: Is it problematic? Gen Hosp Psychiatry. 2000;22(2):78-83.
Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Engl J Med. 2006;354(12):1243-1252.
Nierenberg AA, Fava M, Trivedi MH, et al A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry. 2006;163(9):1519-30.
Thase ME, Friedman ES, Biggs MM, et al. Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. Am J Psychiatry. 2007;164(5):739-52.
How to Switch Antidepressants. Pharmacist's Letter/Prescriber's Letter. 2006;22(220605). Available at: www.pharacistsletter.com. Accessed December 17, 2009.
Staff, H. (2022, January 4). Switching Antidepressant: References, HealthyPlace. Retrieved on 2022, August 17 from https://www.healthyplace.com/depression/switching-antidepressants/switching-antidepressant-references